SCHEMBL14708703

SCHEMBL14708703

COc1cc(O)cc(OS(=O)(=O)c2ccc(N3CCNC3=O)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 11/20 0.53
GAA P10253 1/20 0.45
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KMT2A Q03164 2/20 0.38
ATM Q13315 1/20 0.38
MAOB P27338 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
SCN9A Q15858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2302728 0.94 CYP1A1 (0.58) CYP1A1GAALMNAHTTSMN1; SMN2
SCHEMBL2300655 0.86 CYP1A1 (0.50) CYP1A1GAALMNAHTTSMN1; SMN2
SCHEMBL2302983 0.85 GAA (0.61) CYP1A1GAALMNAHTTSMN1; SMN2
SCHEMBL2234141 0.85 GAA (0.61) CYP1A1GAALMNAHTTSMN1; SMN2
SCHEMBL2303527 0.83 GAA (0.45) CYP1A1GAALMNAHTTSMN1; SMN2
SCHEMBL2302548 0.82 CYP1A1 (0.64) CYP1A1GAASCN9A
SCHEMBL2304336 0.82 CYP1A1 (0.45) CYP1A1GAALMNASMN1; SMN2SCN9A
SCHEMBL2304867 0.81 CYP1A1 (0.44) CYP1A1GAALMNAHTTSMN1; SMN2
SCHEMBL2235366 0.81 CYP1A1 (0.47) CYP1A1GAALMNAHTTSMN1; SMN2
SCHEMBL2299605 0.80 CYP1A1 (0.43) CYP1A1GAALMNASMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013023274-A1 SUBSTITUTED 2-IMIDAZOLIDINONES AND 2-IMIDAZOLONES AND THEIR USE IN THE TREATMENT OF CANCER UNIVERSITE LAVAL (CA) 2013-02-21 WO disclosed